Skip to content
Screener

Quest Diagnostics DGX Other Non-Current Assets

Other Non-Current Assets at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$5.6M-27.3%
Labcorp Holdings logo
Labcorp HoldingsLH
$769.3M+21.5%
Opko Health logo
Opko HealthOPK
$19.49M-1.9%
NeoGenomics logo
NeoGenomicsNEO
$265K+516%
Exagen Inc. logo
Exagen Inc.XGN
$584K-2.0%
Personalis, Inc. logo
Personalis, Inc.PSNL
$3.8M+33.6%

Other financials

Income statement

See full
Revenue$3.0B+10.2%
Gross profit$1.0B+8.9%
Operating income$459.0M+4.8%
Net income$320.0M+13.5%
EPS (diluted)$2.84+15.0%

Balance sheet

See full
Cash & equivalents$626.0M+96.2%
Total debt$6.4B0.0%
Total equity$7.5B+4.0%
Total assets$16.9B+6.1%

Cash flow

See full
Operating cash flow$597.0M+9.7%
CapEx$138.0M+27.8%
Free cash flow$459.0M+5.3%

Valuation

See full
Market cap$26.31B+31.9%
Enterprise value$32.06B+23.3%
P/E24.8×+3.8×
P/S2.3×+0.4×

Profitability

See full
Gross margin33.1%+0.1pp
Operating margin14.1%+0.1pp
Net margin9.2%+0.2pp
FCF margin11.7%0.0pp

Returns & leverage

See full
Return on equity14.4%+0.7pp
Debt / equity0.8×0.0×
Current ratio1.6×+0.5×

Where this comes from

Reported directly by Quest Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Quest Diagnostics’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:16 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001022079-26-000070
Line itemJune 30,2026December 31,2025
Goodwill9,1128,945
Intangible assets, net1,6721,636
Investments in equity method investees137136
Other assets277270
Total assets$16,939$16,225
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable and accrued expenses$1,598$1,600

Cover / Front Matter

FAQ

What is Quest Diagnostics's other non-current assets?
Quest Diagnostics (DGX) reported other non-current assets of $277M in Q2 2026.
How has Quest Diagnostics's other non-current assets changed year-over-year?
Quest Diagnostics's other non-current assets increased by 2.2% year-over-year, from $271M to $277M.
What is the long-term trend for Quest Diagnostics's other non-current assets?
Over 5 years (2020 to 2025), Quest Diagnostics's other non-current assets has grown at a 8.9% compound annual growth rate (CAGR), from $176M to $270M.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.

Ask your AI about Quest Diagnostics's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude